By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Prometheus Laboratories and Medco Research Institute today announced a deal to evaluate Prometheus' test for identifying patients who may benefit from a therapy for inflammatory bowel disease.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: global genetic diversity map, and more.
The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.
In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."
Stat News reports that there's muted opposition to the Kuwaiti DNA database law.